The “Tickle” That Won’t Die: Could You Have Cough Hypersensitivity Syndrome (CHS)?

It started with a tickle. Maybe after a cold that cleared up weeks ago, or after a stressful stretch, or seemingly from nowhere. You coughed. And then you kept coughing. You tried cough drops, antihistamines, reflux medication, and a string of doctor visits where nothing was definitively found and nothing definitively helped. The tickle is still there. The cough still comes.

If that describes your situation, and you’ve been dealing with it for more than two months, the problem almost certainly isn’t allergies, a lingering infection, or anything sitting obviously in your airway. It may be that your cough reflex itself has been changed.

That’s the core of cough hypersensitivity syndrome (CHS), a condition where the neural machinery controlling cough becomes overactive, sensitized to stimuli that a normal cough reflex would simply ignore.

This is a real, recognized, and increasingly well-characterized condition in respiratory medicine. It explains why a persistent cough that won’t go away resists standard treatments, why perfectly healthy people cough when they laugh, inhale cold air, or speak for more than a few minutes, and why the usual cough medicines do almost nothing. Understanding it is the first step toward finding something that actually works.

What Is Cough Hypersensitivity Syndrome (CHS)?

Cough hypersensitivity syndrome is defined clinically as a chronic cough lasting more than eight weeks, triggered by stimuli that would not provoke coughing in a person with a normal cough reflex. Cold air. Perfume. A change in room temperature. Speaking. Laughing. Swallowing. Stimuli this mild have no business activating a cough, but in someone with CHS, they do, reliably and often forcefully.

This is what separates CHS from the three most common causes of chronic cough: upper airway cough syndrome (post-nasal drip), asthma-related airway inflammation, and gastroesophageal reflux disease. Those conditions produce cough through specific, diagnosable pathology that responds to treatment directed at the underlying cause.

Remove the acid reflux or control the asthma, and the cough resolves. In cough hypersensitivity syndrome, the cough persists even after all three of those conditions have been properly evaluated and either ruled out or treated. The cough has become self-sustaining, driven not by ongoing irritation but by a cough reflex that has been fundamentally reset.

The clinical terminology for this state, where the reflex fires too easily, is hypersensitive cough reflex or laryngeal hypersensitivity. The simplest way to understand it is that the threshold for what counts as “enough stimulus to cough” has been dramatically lowered. What was once a protective reflex reserved for genuine airway threats has become a hair-trigger.

Dr. Peter Dicpinigaitis, MD, is blunt about where most chronic dry cough treatment falls short: “When I lecture about cough, I spend a lot of time talking about trying to find these underlying treatable causes of cough, because once we get to the stage of refractory chronic cough, we unfortunately do not have any approved treatments for refractory chronic cough.”

The gap between standard approaches and what refractory cough patients actually need is exactly where CHS sits.

Why Does This Happen? The Science Behind a Persistent Cough

The cough reflex travels through sensory fibers in the larynx and airways, mainly via the vagus nerve to the brainstem. Under normal conditions, these nerves fire only when there’s a real threat, like infection, particles, or aspiration. They have a threshold. Below it, they stay quiet.

After a viral infection or repeated airway irritation, those nerves can become sensitized. Their activation threshold drops, making them hyper-responsive to minor stimuli that wouldn’t normally trigger a cough. At the same time, central processing in the brainstem can amplify the signal, a process known as central sensitization. The result is a persistently overactive cough reflex.

This is why Cough Hypersensitivity Syndrome (CHS) is increasingly grouped with neuropathic pain rather than asthma or reflux. The core issue isn’t ongoing airway inflammation. It’s a neural dysfunction. That’s also why neuromodulators like gabapentin for cough and tricyclic antidepressants show benefit. They target nerve excitability, not inflammation.

A landmark review found strong evidence of increased TRPV1 receptor expression in airway nerves of chronic cough patients and noted that effective treatments such as opioids, gabapentin, and pregabalin share mechanisms with neuropathic pain therapies, reinforcing the neural model.

Post-viral onset is common. After infections like influenza or COVID-19, the illness resolves, but in some patients, the nerve sensitization persists. Many people with a chronic cough trace it back to what seemed like an ordinary respiratory infection that simply never fully reset their cough reflex.

Prof. Alyn Morice, MD, FRCP, explains the sensitization mechanism in words that any patient can understand: “The symptom of cough is usually caused by a high sensitivity in the throat and larynx, and this is due to the nerves’ hypersensitivity. So people cough because of increased sensitivity to a stimulus.”

“If you have a cough/cold or virus, you will be very sensitive here, and if you go out into cold air, you start coughing. That is the hypersensitivity of your nerve causing the cough.” In cough hypersensitivity syndrome, that sensitivity simply never resets.

Read More: Persistent Cough vs. Lung Cancer: When to Worry

Common Triggers That Set Off the Cough Reflex

The triggers in Cough Hypersensitivity Syndrome (CHS) are often ordinary things people don’t initially see as medical. That consistency across patients is actually one of the clearest diagnostic clues.

Talking is a major one. The airflow and vibration during sustained speech can irritate sensitized laryngeal tissue, leading to coughing fits that make phone calls and long conversations difficult.

Cold air is another classic trigger. In most people, it barely causes a reaction. In CHS, stepping into winter air or moving between temperature extremes can reliably provoke coughing. Strong scents, smoke, and chemical odors work the same way by stimulating hypersensitive airway nerves. Even dry foods, swallowing, or subtle throat temperature changes can activate the reflex.

A systematic review and meta-analysis confirmed that patients with CHS report a wide range of triggers matching the temperature, chemical, and mechanical stimuli that activate sensitized laryngeal and airway nerve fibers, with the consistency of this trigger pattern serving as both a diagnostic hallmark and evidence for the hypersensitive cough reflex model.

The Role of the “Throat Tickle” Sensation

The sensation that most patients describe before coughing, the tickle in the throat that won’t go away, is not simply the cough irritation itself. It has a specific clinical name: laryngeal paraesthesia. It’s an abnormal sensory experience in the larynx, an itch, a tickle, or a foreign body sensation that precedes the cough and functions as its trigger.

This urge-to-cough (UTC) phenomenon is an active area of research, and it matters clinically because it means there are two potentially addressable targets in CHS: the neural sensitization itself and the conscious experience of the urge that drives coughing behavior.

Patients who can learn to interrupt the behavioral response to that urge, through behavioral cough therapy, can reduce cough frequency significantly even when the underlying sensitization hasn’t been fully resolved.

In CHS patients, the UTC is present during waking hours but typically absent during sleep. This nocturnal absence is actually a useful diagnostic clue: it suggests the cough is reflex and urge-driven rather than caused by ongoing physical pathology like acid reflux, which would produce coughing regardless of sleep state.

How to Know If It Might Be CHS

The diagnosis of Cough Hypersensitivity Syndrome (CHS) is largely one of exclusion. It’s considered after the three common causes of chronic cough, upper airway cough syndrome, asthma, and GERD have been properly evaluated and treated without resolution. A cough that persists despite adequate therapy is the key diagnostic signal.

CHS more commonly affects middle-aged women, reflecting documented sex differences in cough reflex sensitivity and parallels with neuropathic pain disorders. Still, it occurs in men and across age groups. The demographic pattern should guide suspicion, not limit it.

A European Respiratory Society Task Force recognized CHS as a distinct clinical entity marked by coughing triggered by low-level thermal, mechanical, or chemical stimuli. Most patients report an abnormal throat sensation, like a tickle or itch, before coughing, consistent with laryngeal paresthesia.

Two practical clues stand out: cough typically disappears during sleep, and triggers are broad and unrelated. If cold air, strong smells, laughing, and talking all provoke symptoms, that pattern strongly suggests a sensitized cough reflex rather than a single mechanical cause.

Treatment Options That Actually Target CHS

Neuromodulator Medications

Most over-the-counter cough suppressants, including dextromethorphan and common antihistamines, are designed for short-term viral cough. They act on the acute cough pathway and don’t address the nerve sensitization driving Cough Hypersensitivity Syndrome (CHS). That’s why they rarely help in chronic, unexplained cough.

Gabapentin for chronic cough works at the nerve level. It reduces the excitability of overactive airway neurons by dampening abnormal signaling. A randomized, double-blind trial showed significant improvement in cough severity and quality of life compared to placebo, with benefits appearing by week four. The main limitations were sedation and dizziness, and it’s used off-label since it isn’t FDA-approved specifically for chronic dry cough.

Amitriptyline for chronic cough was used even before gabapentin became common. As a tricyclic antidepressant with neuromodulatory effects, it also reduces hypersensitive nerve firing. Early studies in post-viral vagal neuropathy showed meaningful cough reduction in most patients. Like gabapentin, it’s prescribed off-label and limited by side effects.

Behavioral and Speech Therapy Approaches

Behavioral cough suppression therapy is one of the most evidence-backed non-drug treatments for Cough Hypersensitivity Syndrome (CHS), yet it remains underused. Delivered by trained speech-language pathologists, it addresses both the neurologic sensitization and the behavioral loop that reinforces chronic coughing.

This therapy focuses on helping patients understand the nerve sensitization model and the urge-to-cough cycle. It teaches suppression techniques that interrupt the reflex, along with breathing retraining to reduce laryngeal irritation and voice hygiene strategies to minimize strain on sensitive tissues. For many patients with refractory chronic cough, this approach can significantly reduce symptoms without relying solely on medication.

Prof. Jaclyn Smith, MB ChB, FRCP, PhD, speaks directly to the evidence behind behavioral approaches: “It is possible to train patients with exercises to relax their throat, which I think is helpful so they can get better control of the cough themselves,” she told CBC Radio.

“Techniques like dry swallows, silent yawns, sniffs, and swallows can be taught by speech pathologists and physiotherapists, and there is at least one study suggesting you can cut down on the amount of coughing by about 40 percent.” The technique doesn’t eliminate the sensitization, she notes, but it substantially changes the person’s relationship to the reflex.

Emerging Treatments and Research

P2X3 receptor antagonists are the biggest recent breakthrough in Cough Hypersensitivity Syndrome (CHS) treatment. P2X3 receptors sit on airway sensory nerves and are activated by ATP released during irritation. Blocking these receptors directly interrupts the cough-trigger pathway without the sedation seen with drugs like gabapentin.

Gefapixant, the first agent in this class, showed significant reductions in 24-hour cough frequency in the Phase 3 COUGH-1 and COUGH-2 trials, along with improved quality of life. The main side effect was taste disturbance, affecting about half of the patients at higher doses. It’s approved in Europe and Japan, while the FDA has requested more data.

A pooled analysis published in PMC found that gefapixant 45 mg twice daily significantly reduced 24-hour cough frequency compared to placebo at week 24, with clinically meaningful improvements in cough severity and quality of life.

Newer agents like eliapixant and sivopixant are in development, aiming to reduce taste-related side effects. For patients with refractory chronic cough, these drugs represent a promising targeted option.

When to See a Doctor About a Chronic Cough

A cough lasting eight weeks meets the formal definition of chronic cough, but you don’t always need to wait that long. If it’s been six weeks with no clear cause and no sign of improvement, it’s reasonable to get evaluated.

Certain red flags require immediate attention, regardless of duration. Coughing up blood, unexplained weight loss, worsening shortness of breath, or persistent fever can signal serious conditions like infection, pulmonary embolism, or malignancy. These must be ruled out before considering Cough Hypersensitivity Syndrome (CHS).

Self-diagnosing a persistent cough isn’t wise. The most common causes, post-nasal drip, asthma, and GERD, are often treatable and may fully resolve symptoms. They need proper evaluation and adequate treatment trials first. The issue isn’t exploring CHS; it’s jumping to it before excluding more common and manageable conditions.

Prof. Daiana Stolz, MD, MPH, describes the typical patient journey through the system with sobering accuracy: “a typical patient with chronic cough has usually been coughing for at least 10 years and has undergone hundreds of examinations before being referred to a cough specialist.”

The message for patients is clear: push for a specialist referral, either to a pulmonologist or an ENT with experience in chronic cough, once standard treatments have failed to resolve the problem.

Read More: How to Stop Uncontrollable Coughing: Causes, Relief & When to Seek Help

Living With CHS: Coping and Daily Management Tips

Many people live with Cough Hypersensitivity Syndrome (CHS) for years before getting a clear diagnosis. While medications help some patients, daily strategies can meaningfully reduce cough frequency and improve quality of life.

Hydration is foundational. Dry laryngeal tissue is more reactive, so regular water intake and using a humidifier, especially at night or in air-conditioned spaces, can reduce sensory irritation.

Tracking triggers is equally important. A simple cough diary can uncover patterns tied to certain environments, conversations, scents, or temperature shifts. Not every trigger can be avoided, but identifying high-risk exposures allows practical adjustments without overly restricting daily life.

Breathing retraining targets the reflex itself. Diaphragmatic breathing lowers laryngeal tension, and controlled breathing during the urge-to-cough can interrupt the cough cycle.

Reducing vocal strain also matters. Speak at a comfortable volume, take voice breaks during long conversations, stay hydrated, and avoid habitual throat-clearing. Each throat-clearing mechanically stimulates the larynx and can intensify the urge to cough shortly afterward.

Key Takeaway

A persistent cough that won’t go away for more than eight weeks, triggered by cold air, perfume, speaking, or laughing, with no apparent ongoing cause, is not a minor nuisance and is not something you simply have to live with. It is very likely cough hypersensitivity syndrome, a well-defined condition in which the cough reflex’s neural threshold has been pathologically lowered, and it is increasingly recognized and treatable.

The pathway to that treatment is specific. It starts with proper evaluation and exclusion of the common causes of chronic cough. It continues, if those are excluded or inadequately responsive, with a specialist referral to a pulmonologist or ENT physician experienced in refractory coughs.

From there, the combination of neuromodulator therapy, behavioral cough therapy, and emerging P2X3 receptor antagonists offers a genuinely functional treatment menu that didn’t exist a decade ago.

The throat tickle is real. The nerve malfunction driving it is real. And the growing body of clinical evidence treating it as a real, neurologically based condition rather than a habit or an anxiety symptom is, for the millions of people living with it, long overdue.